
1. malar j. 2011 dec 9;10:350. doi: 10.1186/1475-2875-10-350.

evaluation immunity malaria using luciferase-expressing plasmodium
berghei parasites.

ploemen i(1), behet m, nganou-makamdop k, van gemert gj, bijker e, hermsen c,
sauerwein r.

author information: 
(1)department medical microbiology, radboud university nijmegen medical center
(runmc), nijmegen, netherlands.

background: measurement liver stage development key interest malaria 
biology vaccine studies. parasite development liver cells be
visualized real-time, culture live mice, using transgenic
plasmodium berghei parasite, pbgfp-luccon, expressing bioluminescent reporter
luciferase. study explores benefit using parasites the
evaluation immunity malaria, compared qrt-pcr techniques vivo
and vitro.
methods: mice immunized either radiation attenuated sporozoites (ras)
or wildtype sporozoites chloroquine prophylaxis (cps) challenged with
pbgfp-luccon. vitro transgenic sporozoites neutralization assay (tsna) was
adapted replacing pbcs(pf) parasites pbgfp-luccon parasites.
results: application pbgfp-luccon transgenic parasites provides live
quantitative visual information relation parasite liver load
and protection. moreover, fast reproducible results obtained using
these parasites transgenic sporozoites neutralization assay, measuring
functional antibody-mediated immune responses.
conclusions: pbgfp-luccon parasites straightforward valuable tool for
comprehension biological immunological principles underlying
protection malaria.

doi: 10.1186/1475-2875-10-350 
pmcid: pmc3281144
pmid: 22152047  [indexed medline]

